Rovaldi Christopher
Chief Operating Officer at KROS; SVP, Program Mgmt and Ops at ACCELERON PHARMA INC
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Apr 6, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- KROSKeros Therapeutics, Inc.Chief Operating Officer
- ACCELERON PHARMA INCSVP, Program Mgmt and Ops
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ACCELERON PHARMA INC30,766 shares
- KROS2,592 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ACCELERON PHARMA INCUnusualSep 12, 2017 2017
Sold 14,000 shares at $38.41 ($538k)
Rovaldi Christopher, SVP, Program Mgmt and Ops
Sold 34.2% of holdings ($1.6M position)26,967 shares leftFirst sale on recordFiling
- 2 Form 4 sale ACCELERON PHARMA INCPlan not statedJan 3, 2018 +113 days
Sold 2,266 shares at $42.42 ($96k)
Rovaldi Christopher, SVP, Program Mgmt and Ops
Sold 8.4% of holdings ($1.1M position)24,701 shares leftFiling
- 3 Form 4 sale ACCELERON PHARMA INCUnusualJan 12, 2018 +9 days
Sold 11,000 shares at $45.00 ($495k)
Rovaldi Christopher, SVP, Program Mgmt and Ops
Sold 30.8% of holdings ($1.6M position)24,701 shares leftFiling
- 4 Form 4 sale ACCELERON PHARMA INCPlan not statedApr 3, 2018 +81 days
Sold 3,500 shares at $38.40 ($134k)
Rovaldi Christopher, SVP, Program Mgmt and Ops
Sold 11.9% of holdings ($1.1M position)25,858 shares left0.3x usual sizeFiling
- 5 Form 4 sale KROSUnusualApr 1, 2022 +1459 days
Sold 864 shares at $57.49 ($50k)
Rovaldi Christopher, Chief Operating Officer
Sold 100% of holdings ($50k position)0 shares leftFirst sale on recordFiling
- 6 Form 4 sale KROSUnusualApr 6, 2022 +5 days
Sold 1,728 shares at $65.00 ($112k)
Rovaldi Christopher, Chief Operating Officer
Sold 100% of holdings ($112k position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2022 | Apr 8, 2022 | KROS | Chief Operating Officer | Form 4 sale | 1,728 | $112k | 100.0% | Unusual | SEC |
| Apr 1, 2022 | Apr 5, 2022 | KROS | Chief Operating Officer | Form 4 sale | 864 | $50k | 100.0% | Unusual | SEC |
| Apr 3, 2018 | Apr 4, 2018 | ACCELERON PHARMA INC | SVP, Program Mgmt and Ops | Form 4 sale | 3,500 | $134k | 11.9% | Plan not stated | SEC |
| Jan 12, 2018 | Jan 17, 2018 | ACCELERON PHARMA INC | SVP, Program Mgmt and Ops | Form 4 sale | 11,000 | $495k | 30.8% | Unusual | SEC |
| Jan 3, 2018 | Jan 4, 2018 | ACCELERON PHARMA INC | SVP, Program Mgmt and Ops | Form 4 sale | 2,266 | $96k | 8.4% | Plan not stated | SEC |
| Sep 12, 2017 | Sep 14, 2017 | ACCELERON PHARMA INC | SVP, Program Mgmt and Ops | Form 4 sale | 14,000 | $538k | 34.2% | Unusual | SEC |